[Sonnet Biotherapeutics Receives Shareholder Approval for Business Merger with Hyperliquid Strategies] BlockBeats news, December 2, according to market reports, Sonnet Biotherapeutics has received shareholder approval to merge its business with Hyperliquid Strategies. Previously reported, Hyperliquid Strategies plans to raise up to $1 billion, intended for purchasing HYPE and other assets.